Michael Boeckh, MD, PhD

Head of Infectious Disease Sciences Program, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center ┃ Professor of Medicine, Fred Hutchinson Cancer Center and the University of Washington

Michael Boeckh, MD, PhD, is Head of the Infectious Disease Sciences Program and the Vaccine and Infectious Disease Division at Fred Hutchinson Cancer Center in Seattle, and a Professor of Medicine at the University of Washington. He is an internationally recognized expert in infections in the immuncompromised host with specific interest in herpes and respiratory viruses. His areas of interest are viral kinetics, immune reconstitution and management strategies. Dr. Boeckh received his MD and PhD (Dr. med) degree as well as his internal medicine training from the Freie Universität Berlin, Germany, and completed his infectious disease training at the University of Washington in Seattle.

Life @ AlloVir

Mission-driven teams developing transformative cell therapies for patients deserve transformative benefits. We make sure your life outside the lab is as purposeful as your life inside it.
Life @AlloVir
Trust, commitment, and the drive to build something together. Interested in being part of our vision? Check out our open positions.
Apply Now
PTO Policies
Making sure that you have the freedom to time off when you need to is an important part of our culture. Life beyond the lab includes a flexible approach to PTO; you take it when you need it.
Life @AlloVir
Trust, commitment, and the drive to build something together. Interested in being part of our vision? Check out our open positions.
Apply Now
401k Plans
We offer 401(k) matching, employer-paid life short and long-term disability, and life insurance.
Life @AlloVir
Trust, commitment, and the drive to build something together. Interested in being part of our vision? Check out our open positions.
Apply Now
Healthcare
Our health plans include medical, vision, and dental covered at 90%, as well as Flexible Spending Accounts (FSA) and Dependent Care Accounts (DCA).
Life @AlloVir
Trust, commitment, and the drive to build something together. Interested in being part of our vision? Check out our open positions.
Apply Now
Family Leave
Growing and taking care of your family is as important as the work you do. We offer a generous parental leave program that allows you to do just that.
Life @AlloVir
Trust, commitment, and the drive to build something together. Interested in being part of our vision? Check out our open positions.
Apply Now
Cell phone and commuter reimbursement
Being connected and getting where you need to go is an important part of your work. We offer cell phone and commuter reimbursement programs that acknowledge the time you spend in and out of the office.
Life @AlloVir
Trust, commitment, and the drive to build something together. Interested in being part of our vision? Check out our open positions.
Apply Now

AlloVir is the global leader in developing VST immunotherapies

We develop highly innovative, allogeneic, off-the-shelf, virus-specific T cell (VST) therapies designed to prevent and treat life-threatening viral diseases.

Our Pipeline

Our allogeneic, off-the-shelf VST therapy candidates target 11 different devastating viruses as treatment or prevention.
view

Our Platform

Our proprietary platform develops allogeneic, off-the-shelf VSTs designed to restore immunity in patients with T cell deficiencies.
learn

Our People

We are united in purpose around a singular mission to prevent and defeat life-threatening viral diseases.
meet
AlloVir does not control and is not responsible for the content on the website you are about to visit. AlloVir is providing this link as a convenience, and this link does not imply AlloVir’s endorsement of any material on the website you are about to visit. Do you wish to continue?
AlloVir does not control and is not responsible for the content on the website you are about to visit. AlloVir is providing this link as a convenience, and this link does not imply AlloVir’s endorsement of any material on the website you are about to visit. Do you wish to continue?